logo
Plus   Neg
Share
Email

PDL BioPharma Inc. Q2 adjusted earnings of -$ per share

Below are the earnings highlights for PDL BioPharma Inc. (PDLI):

-Earnings: -$4.42 million in Q2 vs. -$112.30 million in the same period last year.
-EPS: -$0.04 in Q2 vs. -$0.76 in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT
>